10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up
TXG beats Q1 estimates as consumables growth, margin expansion and lower operating costs narrow losses year over year.
Open original sourceLoading market dashboard
TXG beats Q1 estimates as consumables growth, margin expansion and lower operating costs narrow losses year over year.
Open original source